Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the mechanisms of viral pathogenesis and the latest advancements in treatment strategies for various viral infectious diseases. Discussions will include antiviral therapies, vaccine development, and emerging treatment modalities.
This session will explore the molecular epidemiology of viral infections, emphasizing the genetic and environmental factors influencing viral spread and evolution. Researchers will present findings on viral transmission dynamics and population genetics.
This track addresses the public health implications of zoonotic viral diseases, highlighting the transmission pathways from animals to humans. Participants will discuss prevention strategies, surveillance, and control measures.
This session will examine the human immune response to viral infections, including innate and adaptive immunity. Topics will cover immune evasion strategies employed by viruses and the implications for vaccine design.
This track will focus on public health practices aimed at controlling viral infections, including outbreak response, vaccination campaigns, and health education. Case studies will illustrate successful interventions and challenges faced in various settings.
This session will highlight the importance of surveillance systems in detecting and responding to emerging viral threats. Discussions will include global collaboration, data sharing, and the role of technology in outbreak prediction.
This track will delve into the latest innovations in vaccine development for viral diseases, addressing both traditional and novel approaches. Challenges in vaccine distribution, public acceptance, and efficacy will also be discussed.
This session will explore the ethical implications of research and public health interventions related to viral infections. Topics will include informed consent, equity in vaccine distribution, and the balance between individual rights and community health.
This track will focus on viral hemorrhagic fevers, examining clinical presentations, epidemiological trends, and management strategies. Experts will discuss the challenges of diagnosing and treating these severe infections.
This session will cover the latest research on viral hepatitis, including epidemiology, pathogenesis, and treatment options. Discussions will highlight advancements in antiviral therapies and the impact of hepatitis on public health.
This track will address the impact of respiratory viruses on global health, focusing on influenza, coronaviruses, and other respiratory pathogens. Participants will discuss prevention strategies, vaccine development, and the implications for public health policy.